VR-integrated MBCT may improve functional disability and pain bothersomeness in patients with chronic non-specific low back pain (CNLBP) compared to usual care alone.
This protocol describes a randomized controlled trial to evaluate the efficacy and safety of an 8-week VR-integrated mindfulness-based cognitive therapy (VR-MBCT) as an adjunct to usual care in 214 patients with CNLBP. Primary outcomes are the proportions of patients achieving at least 30% improvement in functional disability (Oswestry Disability Index) and pain bothersomeness (0-10 scale) at week 8. The trial is open-label and will analyze data using intention-to-treat generalized estimating equations.
This article is automatically generated from the structured evidence profile behind the claim above. Scores reflect the quality and quantity of available research, not clinical advice.
VR-integrated MBCT may improve functional disability and pain bothersomeness in patients with chronic non-specific low back pain (CNLBP) compared to usual care alone. The current body of evidence comprises 1 study, including 1 randomized controlled trial. EvidenceHub rates the overall confidence at 44/100 (low).
The Claim
VR-integrated MBCT may improve functional disability and pain bothersomeness in patients with chronic non-specific low back pain (CNLBP) compared to usual care alone.
This conclusion is most relevant to: Patients with chronic non-specific low back pain (CNLBP) recruited from pain clinics of three hospitals (n=214)..
What the Research Shows
The conclusion draws on 1 linked study. Highlights from the cited literature:
- ▸Effect of virtual reality-integrated mindfulness-based cognitive therapy on pain and psychological symptoms in chronic non-specific low back pain: protocol for a randomized controlled trial. (Frontiers in digital health, 2026) —
How It Works
The proposed biological pathway:
- ▸VR provides immersive, standardized, and accessible delivery of MBCT
- ▸MBCT enhances mindfulness and cognitive reappraisal of pain
- ▸Reduced pain catastrophizing and kinesiophobia
- ▸Improved functional disability and pain bothersomeness
Who Might Benefit
Evidence fit by population:
- ▸Patients with chronic non-specific low back pain (CNLBP) recruited from pain clinics of three hospitals (n=214).
Recommended Dose
8-week program: weekly in-clinic VR sessions plus daily audio-guided home practice (duration not specified in abstract).
Limitations & Caveats
Important context when interpreting this evidence:
- ▸Open-label design may introduce performance and detection bias
- ▸Results not yet available; only protocol described
- ▸Generalizability limited to patients from pain clinics in three hospitals
Frequently Asked Questions
What is the primary outcome of this trial?▼
The primary outcomes are the proportions of patients achieving at least 30% improvement from baseline in functional disability (ODI) and self-reported back pain bothersomeness (0-10 scale) at week 8.
How long is the VR-MBCT intervention?▼
The intervention lasts 8 weeks, with weekly in-clinic VR sessions supplemented by structured audio-guided home practice.
What is the sample size and randomization?▼
The trial will recruit 214 patients with CNLBP, randomized 1:1 to VR-MBCT plus usual care or usual care alone, using stratified block randomization by center and age (≥60 vs <60).
What safety outcomes are being measured?▼
Safety outcomes include VR-related adverse events such as vertigo, vomiting, nausea, headache, and falls.
References
- 1.Wang P, Yuan J, Gu Q, Dai G, Zhu X, Liu Z, Yu Y, Jin X. “Effect of virtual reality-integrated mindfulness-based cognitive therapy on pain and psychological symptoms in chronic non-specific low back pain: protocol for a randomized controlled trial..” Frontiers in digital health, 2026. PMID: 42614598 DOI: 10.3389/fdgth.2026.1902063